Research location
Tilburg
North Brabant, Netherlands
Advertisement
Research activity in Tilburg
North Brabant, NetherlandsCureCurrent currently publishes aggregate city-level research activity for this location: 17 trials and 17 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Tilburg
17 linked trials · page 1 of 1Discontinuation of Disease-modifying Anti-rheumatic Drugs (DMARDs) in Rheumatoid Arthritis Patients Also Using TNF InhibitorsNCT07802678 · 2026-07-14 · 1 site observation
RECRUITING
REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic DiseasesNCT07160231 · 2025-09-15 · 1 site observation
RECRUITING
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)NCT06841354 · 2025-03-16 · 1 site observation
RECRUITING
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of RecurrenceNCT06492616 · 2024-09-27 · 1 site observation
RECRUITING
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)NCT06136624 · 2023-12-31 · 1 site observation
RECRUITING
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)NCT06170788 · 2023-12-15 · 1 site observation
RECRUITING
DIStal gastriC Bypass OUtcome in Revision SurgEry After Roux-en-y Gastric BypassNCT04894838 · 2021-05-01 · 1 site observation
RECRUITING
PSMA-PET Guided Hypofractionated Salvage Prostate Bed RadiotherapyNCT04642027 · 2020-09-01 · 1 site observation
RECRUITING
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)NCT05288166 · 2022-04-14 · 1 site observation
ACTIVE_NOT_RECRUITING
The Effect of Progressive Resistance Exercise Training (PRET) on CVRF in Adults With ID.NCT06579898 · 2021-12-01 · 1 site observation
COMPLETED
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)NCT04895358 · 2021-06-18 · 1 site observation
ACTIVE_NOT_RECRUITING
MOre REsponse on Cardiac Resynchronization Therapy With MultiPoint PacingNCT02006069 · 2013-12-01 · 1 site observation
TERMINATED
Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)NCT01942135 · 2013-09-26 · 1 site observation
COMPLETED
Improving MEDication Adherence in Chronic Heart Failure Using a TELEmedicine Device (TELEMED-HF)NCT01347528 · 2011-10-01 · 1 site observation
WITHDRAWN
Radiotherapy After Primary Chemotherapy for BreastcancerNCT01279304 · 2011-01-01 · 1 site observation
COMPLETED
The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer PatientsNCT00859768 · 2008-04-01 · 1 site observation
COMPLETED
Drug Interaction Study Between Atovaquone and Antiretroviral Agents in HIV-1 Infected PatientsNCT00421473 · 2007-03-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.